Subject
Gastroenterology,Hepatology
Reference9 articles.
1. Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab;Sousa;Dig Liver Dis,2023
2. Immunomodulator combination versus mono therapy: does combination therapy have an impact on infliximab therapy?;Yuksel,2023
3. Comparison of infliximab with adalimumab in biologic-naïve patients with Crohn's disease: a single-center 13-year experience;Erdoğan;Eur Rev Med Pharmacol Sci,2023
4. Infliximab, azathioprine, or combination therapy for Crohn's disease;Colombel;N Engl J Med,2010
5. Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease;Cosnes;Aliment Pharmacol Ther,2016